Abstract Tetrakis-, tris-, bis-, and mono salicylic acid derivatives 1-4 were synthesized by reaction of methyl 2-hydroxy benzoate (methyl salicylate) with 2,2-bis (hydroxymethyl) propane-1,3-diol (pentaerythritol) in the presence of sodium. Yields of different salicyloyloxy derivatives were changed by varying the molar ratios of reactants. For compounds 2 and 3, X-ray structure analysis was performed, as well as molecular energy minimization, to define their conformation in terms of their energy minima. Comparison of crystal and energy minimized structures for these two compounds (2 and 3) revealed that the intramolecular hydrogen bonds play an important role, stabilizing conformation of the most part of the molecule. The antioxidant activity and cytotoxicity of the synthesized derivatives were evaluated in a series of in vitro tests, as well as 17b-hydroxysteroid dehydrogenase type 2 inhibition potency. Tetrakis salicyloyloxy derivative 1 expressed the highest antioxidant potency, tris salicyloyloxy derivative 2 was the best inhibitor of 17bHSD2 enzyme, while bis salicyloyloxy derivative 3 showed strong cytotoxicity against prostate and breast cancer cells with no cytotoxicity against healthy cells.
Introduction
Attacking biomolecules and thus causing cell or tissue injury, free radicals, originating from metabolism or external sources, could be included in the development of many life-limiting chronic diseases: cancer, cardiovascular diseases, rheumatism, and others [1, 2] . Increasing of antioxidants level in the body could be an effective way to prevent or exceed oxidative stress, where compounds with antioxidant potency may play a significant role. Creation or isolation from natural sources of new molecules with antioxidant properties is a very actual research area, since many naturally occurring or synthetic phenol substances proved to be strong antioxidants. Many phenol substances expressed anticancer activity against various types of carcinomas [3] [4] [5] [6] [7] [8] .
Salicylic acid derivatives, being phenol substances, are biologically very potent: some of them exhibited cytotoxicity against tumor cell lines, some showed antioxidant properties. In many cases, these two activities are connected [9] [10] [11] [12] [13] [14] [15] [16] .
In addition, some phenol substances could influence on the level of circulating steroids by affecting the steroidogenic enzymes, which is of high significance for the treatment of different endocrine disorders [17, 18] . For example, some phenol substances expressed themselves as good inhibitors of 17b-hydroxysteroid dehydrogenase type 2 (17bHSD2), so they are used for the treatment of osteoporosis [19] .
Having in mind all of these facts, in the present study, we continue our investigation of the synthesis of salicylic acid derivatives, which was described in previous papers [14, 15, 20, 21] . We report a simple synthetic route for the preparation of mono-, bis-, tris-, and tetrakis salicyloyl derivatives of 2,2-bis(hydroxymethyl)-propane-1,3-diol (pentaerythritol). Two new compounds were obtained as monocrystals, which allowed their structural analysis. Biochemical studies included testing of antioxidant activity, cytotoxicity, and 17bHSD2 inhibition potency.
Experimental

Chemical synthesis
General IR spectra were recorded on a NEXUS 670 SP-IR spectrometer (wave numbers in cm -1 ). NMR spectra were taken on a Bruker AC 250E spectrometer operating at 250 MHz ( 1 H) and 62.5 MHz ( 13 C) and are reported in ppm (d-scale) downfield from the tetramethylsilane internal standard; coupling constants (J) are given in Hz. Mass spectra were recorded on a Finnigan MAT 8230 instrument, using chemical ionization (isobutane) technique. All the reagents used were of analytical grade. All solutions were dried over anhydrous Na 2 SO 4 .
General procedure for the synthesis of propane-1,3-diyl 2,2-bis(2-hydroxybenzoyloxy)methyl bis(2-hydroxybenzoate) (1), propane-1,3-diyl 2-((2-hydroxybenzoyloxy)methyl)-2-(hydroxymethyl) bis(2-hydroxybenzoate) (2), propane-1,3-diyl 2,2-bis(hydroxymethyl) bis(2-hydroxybenzoate) (3) and 3-hydroxy-2,2-bis(hydroxymethyl)propyl 2-hydroxybenzoate (4).
A mixture consisting of methyl 2-hydroxybenzoate (methyl salicylate; 148 mmol or 23 mmol), 2,2-bis (hydroxymethyl)propane-1,3-diol (pentaerythritol, 37 or 92 mmol), and sodium (3.7 or 7 mmol) was heated on an oil bath at 150°C under atmospheric pressure with the continuos removal of methanol for 2 h. Afterward, distilled water (50 mL) and hydrochloric acid (1:1, to pH 6-7) were added to the residue. The crude product was extracted with ethyl acetate or dichloromethane (5 9 50 mL), dried (anh. Na 2 SO 4 ), and evaporated. Pure compounds were obtained after chromatography of crude product on silica gel column (25 g ).
When molar ratio of methyl salicylate (148 mmol) and 2,2-bis(hydroxymethyl)propane-1,3-diol (37 mmol) was 4:1, the precipitated solid of crude product, obtained after reaction completion, was chromatographed on silica gel column (benzene; benzene-ethyl acetate, 9:1) to give pure compound 1 in a yield of 1 % (0.126 g) after recrystallization from dichloromethane-hexane, mp 174-175°C. Pure compound 2 was obtained in a yield of 19 % (2.141 g) after recrystallization from ethyl acetate-hexane, mp 138-139°C. With further elution with benzene-ethyl acetate (4:1) pure compound 3 was obtained in a yield of 13 % (2.00 g) after recrystallization from acetone-hexane, mp 86.5-87°C ( [21] 86.5-87°C).
According to the general procedure, when molar ratio of methyl 2-hydroxybenzoate (23 mmol) and 2,2-bis (hydroxymethyl)propane-1,3-diol (92 mmol) was 1:4 (in the presence of sodium, 7 mmol), the pure compounds 2-4 were obtained after column chromatography (benzene-ethyl acetate, 9:1, 2:1 and 1:3). Compound 2 was obtained in a yield of 3 % (0.337 g, mp 138°C from dichloromethane-hexane), compound 3 in a yield of 18 % (0.809 g, mp 87°C from dichloromethane-hexane), and compound 4 in a yield of 3 % (0.470 g, mp 174-175°C from dichloromethanehexane [22] . In this reaction procedure, compound 1 was not isolated. 
Crystal structure determination
The diffraction data for compounds 2 and 3 were collected at room temperature on an Oxford Diffraction (Agilent Technologies) Xcalibur diffractometer with graphitemonochromated MoKa radiation (k = 0.7107 Å ). The data reduction was performed with program package CrysAlis RED [23] . The space group determinations were based on an analysis of the Laue class and the systematically absent reflections. The structures were solved by direct methods using SIR92 [24] . All structures were refined using fullmatrix least-squares. For all three compounds, non-hydrogen atoms were refined anisotropically, the C-H hydrogen atoms were included on calculated positions riding on their attached atoms with fixed distances 0.97 Å (CH 2 ) and 0.96 Å (CH 3 ). At the final stage of the refinement, H atoms from the hydroxyl group were positioned geometrically (O-H = 0.82 Å ) and refined using a riding model with fixed isotropic displacement parameters. All calculations were performed using SHELXL97 [25] , PARST [26] , and PLATON [27] , as implemented in the WINGX [28] system of programs. The crystal data and refinement parameters are summarized in Table 1 .
Biological tests
Free radical scavenging assays
Free radical scavenging capacity (RSC) of the synthesized compounds was evaluated by measuring their ability to neutralize 2,2-diphenyl-1-picrylhydrazyl (DPPHÁ) and HOÁ radicals. Final concentrations of the tested compounds were in the range of 0.01-8 mM.
DPPH assay
The DPPH assay was performed as described before [14] . The different aliquots (0.10-2.00 mL) of 0.01 M sample solution in methanol were added to 1.00 mL of 90 lM DPPH Á in methanol (Sigma; St. Louis, MO) and filled up with 95 % (v/v) methanol to a final volume of 4.00 mL. The same reaction mixture without the tested compounds was used as the control. Absorbencies of the reaction mixtures and control were recorded at 515 nm (CECIL CE2021 spectrophotometer) after 1 h. Commercial synthetic antioxidants, 3,5-di-tert-butyl-4-hydroxytoluene (BHT) (Aldrich; Taufkirchen, Germany) and 3-tert-butyl-4-hydroxyanisole (BHA) (Fluka; Taufkirchen, Germany) were used as positive controls. For each sample, three replicates were recorded. The percentage of DPPH radical scavenging capacity (DPPH RSC) was calculated using the following equation:
IC 50 values (the concentration of the tested compound in the reaction mixture which causes 50 % of RSC) were determined by linear regression analysis from the obtained RSC values.
Hydroxyl-radical scavenging assay
Hydroxyl-radicals scavenging capacity (OH Á RSC) of the tested compounds was evaluated by measuring the degradation of 2-deoxy-D-ribose (Aldrich; Taufkirchen, Germany) in the reaction with OH Á radicals, generated in situ in Fenton's reaction [14] . These radicals attack 2-deoxy-Dribose and degrade it into a series of fragments, some or all of which react with 2-thiobarbituric acid (TBA) (Sigma; St. Louis, MO) at low pH and high temperature to give a pink chromogen, which can be determined spectrophotometrically at 532 nm. Different aliquots (0.005-0. 
Three replicates were recorded for each sample. BHT and BHA were used as reference compounds. IC 50 values (the concentration at which 50 % of HO Á is neutralized) were determined by linear regression analysis from the obtained RSC values.
Cytotoxic activity
The cytotoxicity of the synthesized compounds was evaluated using previously described method [29] . The chemotherapy drug doxorubicin (Dox), used as control, was tested under the same experimental conditions.
Cell lines
Three human tumor and one normal cell lines were used in this study: estrogen-receptor positive human breast adenocarcinoma (ER?, MCF-7), estrogen-receptor negative human breast adenocarcinoma (ER-, MDA-MB-231), human prostate cancer (PC-3), and normal fetal lung fibroblasts (MRC-5). These cells were grown in Dulbecco's modified Eagle's medium with 4.5 % of glucose. Media were supplemented with 10 % of fetal calf serum and antibiotics (100 IU/mL of penicillin and 100 lg/mL of streptomycin; ICN Galenika). All cell lines were cultured in flasks (Costar, 25 cm 2 ) at 37°C in 100 % humidity atmosphere and 5 % of CO 2 incubator. Only viable cells were used in the assay. Viability was determined by dye exclusion assay with trypan blue.
Cytotoxicity assay
Cytotoxicity was evaluated by colorimetric sulforhodamine B (SRB) assay [29] . In brief, single cell suspension (5 9 10 3 cells) was plated into 96-well microtiter plates (Costar, flat bottom). Plates were pre-incubated at 37°C in a 5 % CO 2 incubator during 24 h. Tested substances (at final concentrations ranging from 10 -8 to 10 -4 M) were added to all wells except the control ones. After incubation period (48 h/37°C/5 % CO 2 ), cytotoxicity assay was carried out as follows: 50 lL of 80 % trichloroacetic acid was added to all wells; an hour later, the plates were washed with distilled water, and 75 lL of 0.4 % SRB was added to all wells; 30 min later the plates were washed with citric acid (1 %) and dried at room temperature. Finally, 200 lL of 10 mM Tris (pH 10.5) basis was added to all wells. Absorbance was measured on the microplate reader. The wells containing complete medium only, without cells, acted as blank. Cytotoxicity was calculated according to the formula:
Two independent experiments were set out in quadruplicate for each concentration of the compound. The IC 50 (value that defines the dose of compound that inhibits cell growth by 50 %) of compounds was determined by Median effect analysis.
Determination of 17bHSD2 activity and its inhibition in the rat liver microsomal preparation Inhibitory effects exerted on the 17bHSD2 activity by the newly synthesized compounds (1-3) were investigated via conversion of testosterone to androst-4-ene-3,17-dione in vitro. Our previously published radioincubation method for 3bHSD [30, 31] was modified and adapted to the 17bHSD2 measurements. Female rat liver expresses 17bHSD2 constitutively [32] , and served as feasible source of this isozyme. Liver tissue of adult female Wistar rats was homogenized with an Ultra-Turrax in 0.1 M HEPES buffer (pH 7.3) containing 1 mM EDTA and 1 mM dithiothreitol and microsomes were obtained with fractionated centrifugation. Aliquots of the microsomal preparate were incubated with 1 lM After extraction, unlabeled carriers of testosterone and the product androst-4-ene-3,17-dione were added to the samples. The two steroids were separated by TLC on Kieselgel-G (Merck Si 254 F) layers (0.25-mm thick) with the solvent system diisopropyl ether-CH 2 Cl 2 (50:50 v/v) and UV spots were used to trace the separated steroids. Spots were cut out and the radioactivity of the androst-4-ene-3,17-dione formed and of the testosterone remaining was measured by means of liquid scintillation counting. Test compounds were applied at 50 lM concentrations and control incubates without test substances were also prepared in every series. At least two experiments were performed with each test compound and the standard deviations of the mean enzyme activity results were within ±10 %. IC 50 values were determined for more potent inhibitors. In this case, conversion was measured at five or six different concentrations of the test compound between 0.1 and 50 lM. IC 50 results were calculated by linear regression analysis following a logit-log transformation of the data, and the standard deviations were determined from the fitted lines.
Results and discussion
Chemistry
Tetrakis-, tris-, bis-, and mono-salicyloyloxy derivatives 1-4 were synthesized by reaction of methyl salicylate with 2,2-bis (hydroxymethyl)propane-1,3-diol in the presence of sodium, at 150°C for 2 h (Fig. 1) . The molar ratios of reactants were varied in order to increase the yield of the desired products (Table 2) . When molar ratio of methyl salicylate and 2,2-bis (hydroxymethyl)propane-1,3-diol was 4:1, tetrakis derivative 1 was obtained in only 1 % yield, while it was not obtained when molar ratio of reactants was 1:4. Tris derivative 2 was formed in the yield of 19 % (molar ratio 4:1), while in ratio 1:4 only 3 % of 2 were obtained. Compound 3 was obtained in 18 and 13 % yield, in molar ratios 1:4 and 4:1, respectively. Mono salicylic acid derivative 4, however, was obtained only when molar ratio was 1:4, in a very low yield (3 %).
Crystal structures analyses
An ORTEP drawings of molecular structures of compound 2 and 3 are depicted in Figs. 2 and 3 , respectively, while selected bond distances, bond angles, and torsion angles within these compounds are given in Table 3 . C1b-C1-C9a-O4a 57.5 (2)
C1a-C1-C9-O4
ii 174.8 (4) C1a-C1-C9a-O4a 178.52 (16) Compound 2 crystallizes in hexagonal centrosymmetric R -3 space group with threefold axis lying along the direction of C1-C9 bond which means that the atoms C1 and C9 lie in the special position. The asymmetric unit contains the fragment which has one-third of O4-H4 hydroxyl group and one-third of C1 and C9 (including the hydrogen atoms attached to C9) atoms so the other twothirds are symmetry related. The location of O4 and H4 atoms in the unit cell is partial occupied with site occupancy factor equal to 0.33 ( Fig. 2 shows only one O4-H4 hydroxyl group and one pair of hydrogen atoms attached to C9 for clarity). The molecular backbone of asymmetric unit fragment is almost completely planar, except for a rotation on the C1-C9 bond axis that bends the hydroxyl group (see torsions on the C1-C9 bond in Table 3 ).
Compound 3 crystallizes in monoclinic centrosymmetric P2 1 /c space group with two molecules in the asymmetric unit. Intramolecular geometry analysis showed that bond lengths, angles, and torsion angles in molecule of compound 2 are in agreement with the same region of compound 3 (Table 3) .
Hydrogen bonding analyses
The information on intramolecular hydrogen bonding, in particular, is very useful to understand various molecular properties (the molecular geometries, the stability of a certain predominant conformation, and, consequently, biological activity). As can be seen from Figs. 2 and 3, both compounds (2 and 3) contain intramolecular O-H…O hydrogen bonds connecting phenolic hydroxyl group and salicyloyl carbonyl group. In molecular structure of compound 3 two molecules in asymmetric unit are connected by bifurcated, and therefore weaker, hydrogen bonds, involving phenolic hydroxyl group and salicyloyl carbonyl group. Bifurcation of donors and acceptors forms a circle of hydrogen bonds. Crystal packings of two compounds (2 and 3) are illustrated in Fig. 4 . As can be seen from Fig. 4a , crystal packing of compound 3 is dominantly arranged by the dense network of hydrogen bond mostly involving O4 (a,b,c,d) atom as donor or acceptor. The hydrogen bond parameters are given in Table 4 .
Since we wanted to investigate the antioxidant behavior and cytotoxicity of compounds 2 and 3, we were interested in the conformation of molecules released from the influence of crystalline field. The next step, after determining the three-dimensional structures of these compounds in crystalline state, was to define the conformation of the molecules 2 and 3 in terms of energy minima. To do that both molecular geometries were optimized (MMFF94 force field: 500 steps of conjugate gradients followed by 500 steps of steepest descent with a convergence setting of 10e-7) using the program AVOGADRO 1.0.3 [34] .
The conformation of molecules remains stable in their energy minima in spite of the significant number of interatomic single bonds. This is confirmed by comparing selected torsion angles of molecules, obtained in crystal structure analyses and after energy optimization (Table 5 ). Figure 5 illustrates very good overlapping of the molecular structures in crystalline state and after optimization for both compounds (2 and 3). It seems that the presence of intramolecular hydrogen bonds in molecules stabilizes their conformations in spite of the possible influence of crystal packing. As illustrated in Fig. 5 , the intramolecular O-H…O hydrogen bonds in both compounds (2 and 3) are preserved after energy minimization. This is the conformation in which intramolecular hydrogen bonds in compounds stabilize molecular conformation.
Biological properties
Antioxidant activity of the synthesized salicylic acid derivatives
The in vitro antioxidant activity of the synthesized salicyloyloxy derivatives was evaluated and compared with those of commercial antioxidants BHT and BHA (Table 6. ). In the DPPH assay, the ability of tested compounds to act as donors of hydrogen atoms or electrons in transforming DPPH Á into its reduced form, DPPH-H, was measured by spectrophotometric method [14] . All tested compounds were able to reduce the stable purple-colored radical DPPH Á into yellow-colored DPPH-H form, though less than reference compounds (BHA and BHT). Among three tested substances, compound 1, containing four salicyloyl groups (IC 50 0.35 mM), was the most potent, then compound 2, containing three salicyloyl groups, and the less potent was compound 3 possessing only two active groups.
The hydroxyl-radical scavenging activity of the examined compounds was measured by the deoxyribose assay [14] . The protective effects of the tested compounds on 2-deoxy-D-ribose were assessed as their ability to remove hydroxyl radicals (formed in the Fenton reaction) from the test solution and prevent the sugar degradation. The OH radical scavenging activity of the tested compounds was determined indirectly, by measuring the absorbance of the pink-colored solutions. All three compounds tested (1-3) expressed better scavenger properties than reference compounds, while compound 1, possessing four salicyloyl groups, was the most effective (IC 50 0.40 mM).
Cytotoxicity of the synthesized salicylic acid derivatives
The cytotoxic effect of the synthesized compounds against ER?human breast adenocarcinoma (MCF-7), ER-human breast adenocarcinoma (MDA-MB-231), human prostate cancer (PC-3), and normal fetal lung fibroblasts (MRC-5) was examined by the standard SRB assay, after treatment of cells with the tested compounds during 48 h [29] . The results are presented in Table 6 .
As can be seen in Table 6 , bis salicyloyl derivative 3 expressed cytotoxicity against all three tumor cell lines, while it was not toxic against healthy cells. Compound 3 showed the strongest cytotoxicity against prostate cancer PC-3 cells, even 13 times stronger than doxorubicin, while its effect was strong, but a little bit weaker against both breast cancer cell lines, MCF-7 and MDA-MB-231. Compounds 1 and 2 did not influence significantly on the tumor cells proliferation.
It is very important to emphasize that none of the newly synthesized compounds exhibited cytotoxicity against healthy MRC-5 cells. On the contrary, doxorubicin was highly toxic in very small doses.
Effects of the synthesized salicylic acid derivatives on rat 17bHSD2
Inhibitory effects exerted on the 17bHSD2 activity by the newly synthesized compounds (1-3), investigated via measurement of testosterone to androst-4-ene-3,17-dione conversion by an adapted in vitro radiosubstrate incubation method [30] [31] [32] , emphasized tris salicyloyl derivative 2 as the most potent 17bHSD2 inhibitor among the tested compounds (Table 6 ). Namely, IC 50 value for this Symmetry codes: C1b-C1-C9a-O4a 57.5 (2) 66.1
C1a-O1a-C2a-C3a 174.27 (17) 179.3
C1b-O1b-C2b-O2b -0. C1d-O1d-C2d-O2d -2.1 (3) -0.9
C1d-O1d-C2d-C3d 178.17 (19) 179. 4 compound was 1.3 lM, which was 23 times stronger effect than bis salicyloyl derivative 3 and much stronger than tetrakis salicyloyl derivative 1.
Conclusion
The screening of biological properties of the newly synthesized compounds 1-3 showed that they are pharmacologically promising substances, each in different areas of antitumor drug search. Compound 1, containing four salicyloyl groups, was the most potent radical scavenger. Intramolecular geometry analysis of compound 2 and 3 (tris and bis salicyloyl derivatives) did not reveal major differences in their conformations, so it seems that the higher number of salicyloyl groups is the main reason for better antioxidant activity. Tris salicyloyl derivative 2 was potent 17bHSD2 inhibitor. Bis salicyloyloxy derivative 3 showed strong cytotoxicity against prostate and breast cancer cells, while it was not toxic against healthy cells.
Comparison of crystal and energy optimized structures for newly synthesized compounds 2 and 3 revealed that the intramolecular hydrogen bonds play an important role, stabilizing conformation of the most part of molecule. The influence of crystal packing on molecular conformation, including the dense network of intermolecular hydrogen bond especially in compound 3, is not predominant.
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